Fibrosis‐dependent mechanisms of hepatocarcinogenesis

Hepatocellular carcinoma (HCC) is a rising worldwide cause of cancer mortality, making the elucidation of its underlying mechanisms an urgent priority. The liver is unique in its response to injury, simultaneously undergoing regeneration and fibrosis. HCC occurs in the context of these two divergent responses, leading to distinctive pathways of carcinogenesis. In this review we highlight pathways of liver tumorigenesis that depend on, or are enhanced by, fibrosis. Activated hepatic stellate cells drive fibrogenesis, changing the composition of the extracellular matrix. Matrix quantity and stiffness also increase, providing a reservoir for bound growth factors. In addition to promoting angiogenesis, these factors may enhance the survival of both preneoplastic hepatocytes and activated hepatic stellate cells. Fibrotic changes also modulate the activity of inflammatory cells in the liver, reducing the activity of natural killer and natural killer T cells that normally contribute to tumor surveillance. These pathways synergize with inflammatory signals, including telomerase reactivation and reactive oxygen species release, ultimately resulting in cancer. Clarifying fibrosis‐dependent tumorigenic mechanisms will help rationalize antifibrotic therapies as a strategy to prevent and treat HCC. (HEPATOLOGY 2012)

[1]  N. Hayashi,et al.  CD1d‐mediated stimulation of natural killer T cells selectively activates hepatic natural killer cells to eliminate experimentally disseminated hepatoma cells in murine liver , 2003, International journal of cancer.

[2]  P. Kuppen,et al.  Secreted and Membrane-Associated Matrix Metalloproteinases of IL-2-Activated NK Cells and Their Inhibitors1 , 2000, The Journal of Immunology.

[3]  S. Friedman,et al.  Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC. , 2006, Journal of Hepatology.

[4]  S. Meloche,et al.  Liver fibrosis protects mice from acute hepatocellular injury. , 2012, Gastroenterology.

[5]  E. Elinav,et al.  Suppression of hepatocellular carcinoma by transplantation of ex‐vivo immune‐modulated NKT lymphocytes , 2005, International journal of cancer.

[6]  M J Bissell,et al.  Microenvironmental Regulators of Tissue Structure and Function Also Regulate Tumor Induction and Progression : The Role of Extracellular Matrix and Its Degrading Enzymes , 2022 .

[7]  Kenji Ikeda,et al.  Gene expression in fixed tissues and outcome in hepatocellular carcinoma. , 2008, The New England journal of medicine.

[8]  D. Schuppan,et al.  Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. , 2008, The Journal of clinical investigation.

[9]  S. Krane,et al.  Mutation in collagen‐I that confers resistance to the action of collagenase results in failure of recovery from CCl4‐induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  L. Rubbia‐Brandt,et al.  Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans. , 2008, Gastroenterology.

[11]  Y. Deugnier,et al.  Iron and hepatocellular carcinoma , 2001, Journal of gastroenterology and hepatology.

[12]  Laura Beretta,et al.  Extracellular Matrix Dynamics in Hepatocarcinogenesis: a Comparative Proteomics Study of PDGFC Transgenic and Pten Null Mouse Models , 2011, PLoS genetics.

[13]  Eric Vivier,et al.  Functions of natural killer cells , 2008, Nature Immunology.

[14]  J. Dranoff,et al.  Transforming growth factor‐β and substrate stiffness regulate portal fibroblast activation in culture , 2007, Hepatology.

[15]  Long Yu,et al.  Proapoptotic Function of Integrin β3 in Human Hepatocellular Carcinoma Cells , 2009, Clinical Cancer Research.

[16]  F. Stickel,et al.  Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress , 2006, Biological chemistry.

[17]  M. Dembo,et al.  Substrate flexibility regulates growth and apoptosis of normal but not transformed cells. , 2000, American journal of physiology. Cell physiology.

[18]  O. Shibolet,et al.  NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen‐pulsed dendritic cells , 2003, International journal of cancer.

[19]  Marian Brennan,et al.  Integrins as therapeutic targets: lessons and opportunities , 2010, Nature Reviews Drug Discovery.

[20]  Michael Elkin,et al.  Heparanase cleavage of perlecan heparan sulfate modulates FGF10 activity during ex vivo submandibular gland branching morphogenesis , 2007, Development.

[21]  N. Kato,et al.  Risk Assessment of Hepatocellular Carcinoma in Chronic Hepatitis C Patients by Transient Elastography , 2008, Journal of clinical gastroenterology.

[22]  G. Giannelli,et al.  Targeting transforming growth factor (TGF)‐βRI inhibits activation of β1 integrin and blocks vascular invasion in hepatocellular carcinoma , 2009, Hepatology.

[23]  D. V. van Thiel,et al.  Pathogenesis of hepatitis B and C‐induced hepatocellular carcinoma , 1998, Journal of viral hepatitis.

[24]  R. Dhanasekaran,et al.  Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics , 2012, Hepatic medicine : evidence and research.

[25]  M. Yuen,et al.  Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. , 2009, Journal of hepatology.

[26]  P. Janmey,et al.  Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[27]  C. Trautwein,et al.  Functional role of chemokines in liver disease models , 2010, Nature Reviews Gastroenterology &Hepatology.

[28]  Hao Zhang,et al.  β1‐integrin protects hepatoma cells from chemotherapy induced apoptosis via a mitogen‐activated protein kinase dependent pathway , 2002 .

[29]  Jeffrey D. Esko,et al.  Heparan sulphate proteoglycans fine-tune mammalian physiology , 2007, Nature.

[30]  D. Häussinger,et al.  Long-term survival in patients with hereditary hemochromatosis. , 1996, Gastroenterology.

[31]  K. Kwack,et al.  Integrin alpha V polymorphisms and haplotypes in a Korean population are associated with susceptibility to chronic hepatitis and hepatocellular carcinoma , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[32]  D. Albertson,et al.  Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability , 2005, Nature.

[33]  D. Brenner,et al.  Increased expression of collagenase in the liver induces hepatocyte proliferation with cytoplasmic accumulation of beta-catenin in the rat. , 2003, Journal of hepatology.

[34]  Albert Bendelac,et al.  The biology of NKT cells. , 2007, Annual review of immunology.

[35]  G. Karaca,et al.  Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease. , 2009, Gastroenterology.

[36]  E. Merkle,et al.  Hedgehog Signaling Antagonist Promotes Regression of Both Liver Fibrosis and Hepatocellular Carcinoma in a Murine Model of Primary Liver Cancer , 2011, PloS one.

[37]  M. Ozturk,et al.  Senescence and immortality in hepatocellular carcinoma. , 2009, Cancer letters.

[38]  K. Kowdley.  Iron, hemochromatosis, and hepatocellular carcinoma. , 2004, Gastroenterology.

[39]  D. Ron,et al.  Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor , 1996, Cancer and Metastasis Reviews.

[40]  F Verrecchia,et al.  [Cellular and molecular mechanisms of fibrosis]. , 2006, Annales de pathologie.

[41]  Daniel Benten,et al.  Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells , 2011, Hepatology.

[42]  T. Luedde,et al.  NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma , 2011, Nature Reviews Gastroenterology &Hepatology.

[43]  Ze-zhi Wu,et al.  Effects of integrins on laminin chemotaxis by hepatocellular carcinoma cells , 2010, Molecular Biology Reports.

[44]  J. Sicklick,et al.  Sustained activation of Rac1 in hepatic stellate cells promotes liver injury and fibrosis in mice , 2006, Hepatology.

[45]  Hua Tian,et al.  A paracrine requirement for hedgehog signalling in cancer , 2008, Nature.

[46]  S. Forbes,et al.  Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. , 2005, The Journal of clinical investigation.

[47]  R. Wells.  The role of matrix stiffness in regulating cell behavior , 2008, Hepatology.

[48]  H. El‐Serag,et al.  The changing pattern of epidemiology in hepatocellular carcinoma. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[49]  H. El‐Serag.  Epidemiology of hepatocellular carcinoma in USA , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[50]  P. Kuppen,et al.  NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity. , 2003, Trends in immunology.

[51]  N. Hayashi,et al.  Absence of invariant natural killer T cells deteriorates liver inflammation and fibrosis in mice fed high-fat diet , 2010, Journal of Gastroenterology.

[52]  G. Karaca,et al.  Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease , 2010, Hepatology.

[53]  Francesco Donato,et al.  Hepatocellular carcinoma in cirrhosis: incidence and risk factors. , 2004, Gastroenterology.

[54]  W. Jeong,et al.  Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis. , 2008, Gastroenterology.

[55]  Rocio Lopez,et al.  The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis , 2010, Hepatology.

[56]  K. Boudjema,et al.  Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas , 2001, Hepatology.

[57]  P. Malfertheiner,et al.  Hepatocellular Carcinoma – Epidemiological Trends and Risk Factors , 2009, Digestive Diseases.

[58]  D. Leibfritz,et al.  Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.

[59]  Zhigang Tian,et al.  Liver: An organ with predominant innate immunity , 2007, Hepatology.

[60]  G. Karaca,et al.  Hedgehog signaling is critical for normal liver regeneration after partial hepatectomy in mice , 2010, Hepatology.

[61]  Raghu Kalluri,et al.  Fibroblasts in cancer , 2006, Nature Reviews Cancer.

[62]  D. Rifkin,et al.  LTBPs, more than just an escort service , 2012, Journal of cellular biochemistry.

[63]  Mikala Egeblad,et al.  Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.

[64]  S. Friedman.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. , 2008, Physiological reviews.

[65]  D. Doherty,et al.  Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure , 2008, Gut.

[66]  P. Schirmacher,et al.  Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice. , 2006, Journal of hepatology.

[67]  D. Harnois.  Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease , 2009 .

[68]  J. Fassett,et al.  Regulation of hepatocyte cell cycle progression and differentiation by type I collagen structure. , 2006, Current topics in developmental biology.

[69]  C. Lees,et al.  The hedgehog signalling pathway in the gastrointestinal tract: implications for development, homeostasis, and disease. , 2005, Gastroenterology.

[70]  Young Nyun Park,et al.  Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis , 2007, Hepatology.

[71]  J. Iredale,et al.  Impaired Proteolysis of Collagen I Inhibits Proliferation of Hepatic Stellate Cells , 2006, Journal of Biological Chemistry.

[72]  R. Wells,et al.  The role of stem cells in liver repair and fibrosis. , 2011, The international journal of biochemistry & cell biology.

[73]  W. Mehal,et al.  Cell death and fibrogenesis. , 2010, Seminars in liver disease.

[74]  W. Jeong,et al.  Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride , 2009, Hepatology.

[75]  K. Iwaisako,et al.  Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis. , 2008, Gastroenterology.

[76]  D. Rifkin,et al.  Latent Transforming Growth Factor β-binding Protein 1 Interacts with Fibrillin and Is a Microfibril-associated Protein* , 2003, The Journal of Biological Chemistry.

[77]  R. Eferl,et al.  Hepatic tumor–stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge , 2009, Oncogene.

[78]  D. Speiser,et al.  Enrichment of Human CD4+ Vα24/Vβ11 Invariant NKT Cells in Intrahepatic Malignant Tumors 1 , 2009, The Journal of Immunology.

[79]  Angelique Zeringue,et al.  Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. , 2011, Gastroenterology.

[80]  R. Sun,et al.  Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. , 2006, Gastroenterology.

[81]  A. Manduca,et al.  Assessment of hepatic fibrosis with magnetic resonance elastography. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[82]  H. Mochizuki,et al.  Decrease of CD56+T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma , 2000, Hepatology.